BrightInsight fetches $101m Series C

BrightInsight, a provider of a global regulated digital health platform for biopharma and medtech, has secured $101 million in Series C financing.

BrightInsight, a provider of a global regulated digital health platform for biopharma and medtech, has secured $101 million in Series C financing. General Catalyst led the round.

Source: Press Release